Angelo Antonini

38.9k total citations · 4 hit papers
529 papers, 21.0k citations indexed

About

Angelo Antonini is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Angelo Antonini has authored 529 papers receiving a total of 21.0k indexed citations (citations by other indexed papers that have themselves been cited), including 442 papers in Neurology, 103 papers in Cellular and Molecular Neuroscience and 66 papers in Cognitive Neuroscience. Recurrent topics in Angelo Antonini's work include Parkinson's Disease Mechanisms and Treatments (408 papers), Neurological disorders and treatments (314 papers) and Botulinum Toxin and Related Neurological Disorders (70 papers). Angelo Antonini is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (408 papers), Neurological disorders and treatments (314 papers) and Botulinum Toxin and Related Neurological Disorders (70 papers). Angelo Antonini collaborates with scholars based in Italy, United Kingdom and United States. Angelo Antonini's co-authors include Gianni Pezzoli, Klaus L. Leenders, Per Odin, К. Ray Chaudhuri, David Eidelberg, Roberta Biundo, Pablo Martínez‐Martín, Werner Poewe, Luca Weis and Vijay Dhawan and has published in prestigious journals such as New England Journal of Medicine, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Angelo Antonini

511 papers receiving 20.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease

2007 575 citations Angelo Antonini et al. profile →
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

2013 487 citations Per Odin, Angelo Antonini et al. profile →
European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies

2022 100 citations Günther Deuschl, Angelo Antonini et al. Movement Disorders profile →
Parkinson disease therapy: current strategies and future research priorities

2024 49 citations Fabrizio Stocchi, Angelo Antonini et al. profile →

Peers

Countries citing papers authored by Angelo Antonini

Since Specialization

Citations

This map shows the geographic impact of Angelo Antonini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Antonini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Antonini more than expected).

Fields of papers citing papers by Angelo Antonini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Antonini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Antonini. The network helps show where Angelo Antonini may publish in the future.

Co-authorship network of co-authors of Angelo Antonini

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Antonini. A scholar is included among the top collaborators of Angelo Antonini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Antonini. Angelo Antonini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Insights From a Mixed Methods Analysis of 3 Health Technologies Used in Patients With Parkinson Disease: Mixed Methods Study 2025 ·Journal of Medical Internet Research ·(unknown), Mariana H.G. Monje, Sylvie Grosjean, (unknown), (unknown), Raquel Bouça‐Machado, (unknown), (unknown), (unknown), Timothy Lynch, (unknown), Dimitrios I. Fotiadis, George Rigas, Evžen Růžička, Joaquim J. Ferreira, Angelo Antonini, Norberto Malpica, Tiago Mestre, Álvaro Sánchez‐Ferro	0
2	Effects of virtual reality cognitive training on executive function and prospective memory in Parkinson's disease and healthy aging 2025 ·Journal of the Neurological Sciences ·Eleonora Fiorenzato, Silvia Zabberoni, Maria Stefania De Simone, Alberto Costa, Gaetano Tieri, (unknown), Antonella Peppe, Giovanni Augusto Carlesimo, Carlo Caltagirone, Angelo Antonini, Giorgia Cona	2
3	Opicapone as adjunct to levodopa in treated Parkinson's disease without motor complications: A randomized clinical trial 2025 ·European Journal of Neurology ·Joaquim J. Ferreira, Olivier Rascol, Fabrizio Stocchi, Angelo Antonini, (unknown), (unknown), José‐Francisco Rocha, (unknown), Werner Poewe, (unknown)	2
4	Role of zonisamide in advanced Parkinson’s disease: a randomized placebo-controlled study 2024 ·Neurological Sciences ·(unknown), Eman Hamid, (unknown), (unknown), Angelo Antonini, Ali Shalash	2
5	Facial emotion recognition in individuals with mild cognitive impairment: An exploratory study 2024 ·Cognitive Affective & Behavioral Neuroscience ·Francesca Burgio, Arianna Menardi, Silvia Benavides‐Varela, (unknown), Andreina Giustiniani, Jan Van den Stock, (unknown), Roberta Biundo, Francesca Meneghello, Angelo Antonini, Antonino Vallesi, Béatrice de Gelder, Carlo Semenza	5
6	Late olfactory bulb involvement in COVID-19 2024 ·Chemical Senses ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anna Bordin, Giancarlo Ottaviano, Piergiorgio Gaudioso, Alessandra Bertoldo, (unknown), Alessandro Miola, (unknown), Riccardo Ceccato, Carla Mucignat‐Caretta, Angelo Antonini, Renzo Manara	1
7	Validation of the Italian version of the Parkinson’s Disease- Cognitive Functional Rating Scale 2024 ·Journal of Neural Transmission ·(unknown), Luca Weis, (unknown), Eleonora Fiorenzato, (unknown), (unknown), Margherita Canesi, (unknown), E. Reali, (unknown), Ioannis U. Isaias, Chiara Siri, Gabriella Santangelo, Sofia Cuoco, Paolo Barone, Jaime Kulisevsky, Angelo Antonini, Roberta Biundo	3
8	Persistent and transient olfactory deficits in COVID-19 are associated to inflammation and zinc homeostasis 2023 ·Frontiers in Immunology ·(unknown), Anna Bordin, Gabriele Sales, (unknown), (unknown), Alberto Biscontin, (unknown), Alfredo Garzino‐Demo, Angelo Antonini, Giancarlo Ottaviano, Carla Mucignat‐Caretta, Cristina Parolin, Arianna Calistri, Cristiano De Pittà	5
9	Toward objective monitoring of Parkinson's disease motor symptoms using a wearable device: wearability and performance evaluation of PDMonitor® 2023 ·Frontiers in Neurology ·Angelo Antonini, Heinz Reichmann, Giovanni Gentile, (unknown), (unknown), (unknown), Björn Falkenburger, Spyridon Konitsiotis, Konstantinos I. Tsamis, George Rigas, Nicholas Kostikis, (unknown), Constantinos S. Pattichis	33
10	Combining Transcranial Magnetic Stimulation and Deep Brain Stimulation: Current Knowledge, Relevance and Future Perspectives 2023 ·Brain Sciences ·Valentina D’Onofrio, Nicoletta Manzo, Andrea Guerra, Andrea Landi, Valentina Baro, Sara Määttä, Luca Weis, Camillo Porcaro, Maurizio Corbetta, Angelo Antonini, Florinda Ferreri	11
11	The role of opicapone in the management of Parkinson's disease: an Italian consensus through a combined Nominal Group Technique and Delphi approach. 2023 ·PubMed ·Angelo Antonini, Paolo Barone, Paolo Calabresi, Leonardo Lopiano, Francesca Morgante, Francesco E. Pontieri, Mariachiara Sensi, Fabrizio Stocchi	1
12	European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies breakdown → 2022 ·Movement Disorders ·Günther Deuschl, Angelo Antonini, João Costa, Katarzyna Śmiłowska, Daniela Berg, Jean‐Christophe Corvol, Giovanni Fabbrini, Joaquim J. Ferreira, Thomas Foltynie, Pablo Mir, Anette Schrag, Klaus Seppi, Pille Taba, Evžen Růžička, Marianna Selikhova, Nicholas Henschke, Gemma Villanueva, Elena Moro	100
13	Action Selection and Motor Decision Making: Insights from Transcranial Magnetic Stimulation 2022 ·Brain Sciences ·(unknown), Andrea Guerra, Lorenzo Rocchi, Sara Määttä, Matteo Bologna, María Herrojo Ruiz, Roberta Biundo, Angelo Antonini, Florinda Ferreri	5
14	Dysphagia predicts poor outcome in late-stage Parkinson's disease 2019 ·Parkinsonism & Related Disorders ·Margherita Fabbri, Miguel Coelho, Daisy Abreu, Leonor Correia Guedes, Mário Miguel Rosa, Catarina Godinho, Rita M. Cardoso, Isabel Guimarães, Angelo Antonini, Maurizio Zibetti, Leonardo Lopiano, Joaquim J. Ferreira	29
15	Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease 2018 ·Movement Disorders ·Haidar S. Dafsari, Monty Silverdale, (unknown), Alexandra Rizos, Keyoumars Ashkan, (unknown), (unknown), Julia Steffen, Till A. Dembek, Veerle Visser‐Vandewalle, Julian Evans, Angelo Antonini, Pablo Martínez‐Martín, К. Ray Chaudhuri, Lars Timmermann, (unknown)	69
16	Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts 2018 ·Brain stimulation ·Haidar S. Dafsari, Jan Niklas Petry‐Schmelzer, К. Ray Chaudhuri, Keyoumars Ashkan, Luca Weis, Till A. Dembek, Michael Samuel, Alexandra Rizos, Monty Silverdale, Michael T. Barbe, Gereon R. Fink, Julian Evans, Pablo Martínez‐Martín, Angelo Antonini, Veerle Visser‐Vandewalle, Lars Timmermann	51
17	Nonmotor Symptoms and Natural History of Parkinson's Disease: Evidence From Cognitive Dysfunction and Role of Noninvasive Interventions 2017 ·International review of neurobiology ·Roberta Biundo, Eleonora Fiorenzato, Angelo Antonini	13
18	Device-Aided Treatment Strategies in Advanced Parkinson's Disease 2017 ·International review of neurobiology ·(unknown), (unknown), (unknown), Per Odin, Angelo Antonini	40
19	Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence? 2017 ·eNeurologicalSci ·María José Catalán, Angelo Antonini, Matilde Calopa, Ovidiu Băjenaru, Oriol de Fàbregues, Adolfo Mínguez‐Castellanos, Per Odin, J M García-Moreno, Stephen Wørlich Pedersen, Zvezdan Pirtošek, Jaime Kulisevsky	10
20	Pain in Parkinson's disease: Observational study of 225 patients 2011 ·UCL Discovery (University College London) ·(unknown), Alexandra Rizos, (unknown), Y. Naidu, (unknown), Anthony H.V. Schapira, Pablo Martínez‐Martín, Angelo Antonini, Cristian Falup‐Pecurariu, Per Odin, К. Ray Chaudhuri	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact